Skip to main content

Table 2 Comparison of laboratory test results among three groups

From: Correlation analysis of epicardial adipose tissue thickness, C-reactive protein, interleukin-6, visfatin, juxtaposed with another zinc finger protein 1, and type 2 diabetic macroangiopathy

 

Complication Group

(n = 82)

Diabetes Group

(n = 85)

Healthy Control Group

(n = 90)

χ2/t

P

FPG (mmol/L)

12.45 ± 1.29a,b

9.39 ± 1.04b

5.39 ± 0.87

936.87

<0.001

HbA1C (%)

9.81 ± 0.17b

9.01 ± 0.26b

5.56 ± 0.54

3328.435

<0.001

TC (mmol/L)

4.78 ± 1.17

4.69 ± 1.12

4.39 ± 1.02

2.988

0.052

TG (mmol/L)

2.38 ± 0.13b

2.33 ± 2.08b

1.79 ± 0.37

6.315

0.002

HDL-C (mmol/L)

1.17 ± 0.41

1.11 ± 0.37

1.03 ± 0.37

2.897

0.057

LDL-C (mmol/L)

3.02 ± 0.98

2.85 ± 0.91

2.76 ± 0.91

1.704

0.184

CRP (mg/mL)

6.78 ± 0.47a,b

3.45 ± 0.21b

2.49 ± 0.24

4071.146

<0.001

IL-6 (pg/mL)

123.93 ± 30.93a,b

80.99 ± 12.39b

64.39 ± 8.73

209.132

<0.001

Visfatin (pg/mL) [M (QL,QU)]

667.93 (340.83,1093.89)a,b

372.79 (334.93,470.93)*

358.73 (332.98,428.71)

183.09

<0.001

JAZFl (pg/mL) [M (QL,QU)]

122.29 (86.39,253.29)a,b

153.39 (132.91,203.29)b

221.92 (204.92,341.92)

208.11

<0.001

FIns (μIU/mL)

12.09 ± 1.21b

12.06 ± 1.34b

15.41 ± 2.01

131.363

<0.001

HOMA-IR

6.54 ± 0.37a,b

4.62 ± 0.36b

3.56 ± 0.32

1586.769

<0.001

EAT thickness (mm)

5.58 ± 1.23a,b

3.58 ± 0.78b

2.71 ± 0.54

233.854

<0.001

baPWV

1698.23 ± 227.89a,b

1607.46 ± 236.41a,b

1320.28 ± 112.13

96.625

< 0.001

  1. FPG fasting plasma glucose, HbA1C hemoglobin A1C, TC total cholesterol, TG triglyceride, HDL-C high density lipoprotein cholesterol, LDL-C low density lipoprotein cholesterol, CRP C-reactive protein, IL-6 interleukin-6, FIns fasting insulin, HOMA-IR homeostasis model assessment of insulin resistance, EAT epicardial adipose tissue
  2. acompare with Diabetes Group (P<0.05); bcompare with Healthy Control Group (P<0.05)